India's OneSource Specialty Pharma has received Saudi Food and Drug Authority (SFDA) approval of its generic Oze...
India-based Morepen Laboratories, a global leader in Active Pharmaceutical Ingredient (API) manufacturing, has received ...
Patent cliffs will be one of the originator's biggest pain points in the next 3-5 years. Between the originator and bios...
By 2030, pharmaceutical companies are expected to lose over $236 billion in revenue due to the impending ‘patent c...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, ...
Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...
Apexelsin, a generic drug from China been approved by the European Commission. Apexelsin is a generic dru...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...
How did the company perform during FY 2022-23? The company is currently in a recovery phase following the impact ...
The Medicines Patent Pool (MPP), a United Nations-backed public health organisation, has signed sublicence agreemen...
Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...
Indian pharmaceutical company Venus Remedies has received marketing authorisation for its generic cancer drugs from Uzbe...
Trans-Atlantic private equity healthcare specialist ArchiMed has invested in Bielefeld, Germany-based PlasmidFactory. Fo...
Pharmaceutical companies need to ensure they have a competitive edge in the market while adapting to evolving industry b...
The Medicines Patent Pool (MPP) has signed agreements with 35 companies to manufacture the generic version of Pfizer's o...
Eisai Co. has announced that LENVIMA (generic name: lenvatinib mesylate), the multiple receptor tyrosine kinase inh...
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...
Indian firm Biocon has announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary...
Multiple regulatory filings have been submitted to expand distribution channels globally across China, Taiwan, South Kor...
Gene therapies will provide a valid treatment option for patients that have developed resistance to chemotherapies acros...
US-based Metagenomi, a next generation gene editing company launched by UC Berkeley scientists in 2018, successfully com...
These EVs are known to mediate many of the therapeutic effects of stem cells. The authors show that Austrianova’s ...
Following the recent news that Dr Reddy's Laboratories (DRL) has agreed to acquire Wockhardt Ltd’s select division...
Japan based TOWA PHARMACEUTICAL CO., LTD. and Spain based pharma company ESTEVE have announced that TOWA will acquire 10...
Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...
The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...
Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...
Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...
Dr. Reddy’s Laboratories along with its subsidiaries, together referred to as “Dr. Reddy’s confirms it...
Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...
Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...
Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...
Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...
Teva Pharmaceutical Industries has announced the availability of the FDA-approved generic version of EpiPen Jr®1&nbs...
Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...
Teva Pharmaceutical Industries Ltd. has announced the launch of a generic version of Tracleer® (bosentan) tablets, 6...
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...
GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...
Mayne Pharma Group Limited has announced that the US Food and Drug Administration (FDA) has approved SORILUX® (...
Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMP...
Alembic has entered into a Joint Venture Agreement ('JVA') with SPH SINE Pharmaceutical Laboratories Co Ltd, China ('SPH...
CStone Pharmaceuticals and Numab Therapeutics AG have entered into an exclusive regional licensing agreement for the dev...
EirGenix, Inc. has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, gran...
Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of AndroGel ®i (testosterone...
Teva Pharmaceutical has announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Su...
Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...
Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a S...
Regeneron Pharmaceuticals and Sanofi recently announced that the European Medicines Agency's Committee fo...
Pharma major Lupin announced that it has received approval for its Azacitidine for Injection, 100 mg Single-Dose Vial fr...
Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treat...
Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United State...
Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States ...
India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdo...
Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmetero...
Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application ...
Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (...
Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 m...
Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...
Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology inject...
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...
Telangana based Pharma company, Hetero has announced that its European subsidiary Amarox Limited has acquired Tarbis Far...
JHL Biotech announced today that the first patient at Beijing Cancer Hospital has been successfully randomized in t...
Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...
Dr. Reddy’s has announced the launch of Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivale...
Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...
Dr. Reddy’s has announced the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store...
Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...
Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...
Aurobindo Pharma Limited, a world-leading marketer and manufacturer of generic pharmaceuticals and active pharmaceutical...
Jeil Pharmaceutical has recently opened a new technology research centre in Yongin, Gyeonggi Province. The new research...
Singapore — GB Sciences has completed the technology transfer for the manufacturing of time-released nanoparticles...
Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatm...
Pharma major Lupin announced the launch of its Memantine Hydrochloride Extended-Release Capsules, 7mg, 14mg, 21mg, 28mg ...
GSK has recently announced that the expanded indication for Fluarix Tetra (Quadrivalent Influenza Vaccine) has been appr...
Pharma major Lupin has announced the launch of its Clobetasol Propionate Lotion 0.05% having received an approval from t...
In a significant development for Indian patients requiring treatment for structural or congenital heart disease and defe...
Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharm...
Singapore - The positive one-year results of a Heart Failure Telehealth programme, piloted by Changi General Hospital (C...
Singapore - NPL, the UK's National Measurement Institute (NMI) and UCL (University College London) have engineered a bra...
Singapore - Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight com...
Singapore - A new international study has made an important discovery about the key role of macrophages, a type of immun...
Singapore - Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the Sp...
Adapsyn Bioscience Inc., a biotechnology company focused on the discovery and development of novel medicines derived fro...
Sangamo Therapeutics, Inc. and Pfizer has announced a collaboration for the development of a potential gene therapy usin...
Michigan based veterinary pharmaceutical and diagnostic company, Zomedica Pharmaceuticals has announced that it has ente...
Array BioPharma has announced that it has entered into a clinical trial collaboration agreement with Pfizer to investiga...
Sanofi and Regeneron has announced positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous s...
Sanofi will host an analyst meeting in Paris today to discuss the company’s Research and Development strategy, dev...
Singapore - In the first comprehensive analysis of clinical trial enrolment among older adults with blood cancers, resea...
US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple m...
Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food...
Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the comp...
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacifi...
Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food an...
US based biotech company Biogen and pharma company Alkermes has announced that they have entered into a global lic...
Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with...
